Recent

% | $
Quotes you view appear here for quick access.

ANI Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • stockkarr stockkarr Oct 30, 2009 11:44 AM Flag

    Let's just talk about the potential market for FSD!

    I'm wary about the pick-up for Libigel because of who it is targeting - older women. I think a good analogy is female hair loss - nearly as big an issue as it is for men, but basically under the radar. Women of that age/era generally prefer to deal with problems, push them aside, then pursue solutions.

    Also - I've been talking to a lot of women about the potential for this product and many of them are rather skeptical. By the time a younger, more open generation comes around, patent expiry may be an issue, unless they're able to cement branding and make it synonymous with FSD.

    That said, I'm happy to see what happens - bit of a reluctant long here, I guess.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ANIP
52.28-3.32(-5.97%)May 6 4:00 PMEDT